🔍 VULNERABILITY EXPOSURE ASSESSMENT
Are your systems exposed to this vulnerability? CYBERDUDEBIVASH® provides rapid vulnerability assessments covering API attack surfaces, cloud infrastructure, web applications, and network perimeter — with remediation-ready reports.
Executive Summary
The Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT has been found to be vulnerable to exploitation, allowing attackers to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device. The affected versions are 0x0110_v1.1.0, with CVE-2026-50034 and CVE-2026-52866 having a CVSS score of 6.5. This vulnerability poses a significant risk to healthcare and public health sectors, particularly in India where the company is headquartered.
Threat Analysis
The attack vector for this vulnerability is through Bluetooth Low Energy (BLE) communication, where an attacker within range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values. The affected product is the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), version 0x0110_v1.1.0. The exploitation methodology involves intercepting BLE communications, which can be done using readily available tools. CVE-2026-50034 and CVE-2026-52866 are the specific vulnerabilities that have been identified, with the former allowing an attacker to obtain sensitive health-related information and the latter related to missing authorization.
Business Impact Assessment
The risk to enterprises is significant, particularly those in the healthcare and public health sectors. The potential consequences of exploitation include the unauthorized disclosure of sensitive health-related information, which could have serious reputational and financial implications. Additionally, the prevention of legitimate users from establishing a connection with the device could have operational implications, particularly in situations where timely access to glucose measurement values is critical. While the exact financial impact is difficult to quantify, it is likely to be substantial, given the potential for reputational damage and the costs associated with notifying and supporting affected individuals.
SOC Recommendations — Immediate Actions
- Identify and isolate all Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT devices with version 0x0110_v1.1.0
- Block all BLE communications to and from these devices until a patch or mitigation is available
- Monitor for suspicious BLE activity in the vicinity of these devices
- Reach out to Apollo Pharmacy directly for more information on mitigations and patches: https://www.apollopharmacy.in/contact-us
MITRE ATT&CK Mapping
- Tactic: Reconnaissance (TA0043): Technique - T1614 (Bluetooth)
- Tactic: Collection (TA0009): Technique - T1204 (Credential Dumping)
Detection Opportunities
Log sources to monitor include BLE communication logs, device connection logs, and system event logs. Network signatures to monitor include unusual BLE traffic patterns, such as unexpected connections or data transfers. Behavioral indicators to monitor include suspicious device behavior, such as unexpected reconnections or changes in communication patterns.
Threat Hunting Recommendations
- Hunt for unusual BLE traffic patterns in the vicinity of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT devices
- Investigate suspicious device behavior, such as unexpected reconnections or changes in communication patterns
- Search for potential indicators of compromise, such as unauthorized access to sensitive health-related information
CYBERDUDEBIVASH® Analyst Commentary
This vulnerability highlights the importance of securing medical devices, particularly those that transmit sensitive health-related information. The use of BLE communication protocols, while convenient, also introduces significant security risks if not properly secured. As the healthcare and public health sectors continue to rely on these devices, it is essential that manufacturers prioritize security and provide timely patches and mitigations for identified vulnerabilities. Additionally, enterprises must be proactive in identifying and addressing these vulnerabilities to minimize the risk of exploitation.
Enterprise Recommendations
- Conduct a thorough inventory of all medical devices, including the Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT, to identify potential vulnerabilities
- Develop and implement a comprehensive patch management program to ensure timely application of patches and mitigations
- Provide training to users on the importance of security and the potential risks associated with medical devices
- Consider implementing additional security controls, such as encryption and secure communication protocols, to protect sensitive health-related information
Key Takeaways
- The Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT is vulnerable to exploitation, allowing attackers to obtain sensitive health-related information
- The affected versions are 0x0110_v1.1.0, with CVE-2026-50034 and CVE-2026-52866 having a CVSS score of 6.5
- The attack vector is through BLE communication, and the exploitation methodology involves intercepting BLE communications
- The risk to enterprises is significant, particularly those in the healthcare and public health sectors
- Immediate actions include identifying and isolating affected devices, blocking BLE communications, and monitoring for suspicious activity
🛡 SENTINEL APEX ECOSYSTEM
Get real-time threat intelligence, CVE analysis, YARA/Sigma rules, and SOC-ready intelligence feeds trusted by 4,800+ security professionals worldwide.
🔗 Related Intelligence Resources
📩 WEEKLY THREAT INTELLIGENCE BRIEFING
Join 2,400+ security professionals receiving CYBERDUDEBIVASH® weekly intelligence briefings — curated CVE alerts, APT campaign updates, AI security advisories, detection rule drops, and SOC operational intelligence.
Free tier · No spam · Unsubscribe anytime · Enterprise tier available
🏢 CYBERDUDEBIVASH® Enterprise Services
⎋ THREAT INTELLIGENCE API — FREE TIER AVAILABLE
Integrate live CVE data, KEV alerts, malware intelligence, and AI threat summaries directly into your security stack — Splunk, Elastic, Microsoft Sentinel, SOAR, or custom tooling. RESTful JSON API. No vendor lock-in.
🎯 Detection Engineering Packs — Instant Download
2,400+ production-ready Sigma detection rules, YARA malware signatures, and IR playbooks — mapped to MITRE ATT&CK. Deploy to Splunk, Elastic, or Microsoft Sentinel in minutes. Updated weekly by CYBERDUDEBIVASH® analysts.
meta: author = "CYBERDUDEBIVASH® SENTINEL APEX" severity = "CRITICAL"
strings: $smb_pipe = "\\IPC$" $psexec = "PSEXESVC"
condition: all of them
}
#CyberSecurity #ThreatIntelligence #CyberDudeBivash #SentinelAPEX
CYBERDUDEBIVASH® is an AI-native cybersecurity ecosystem specializing in Threat Intelligence, AI Security, SOC Operations, Managed Security Services, Incident Response, Threat Hunting, Security Automation, DevSecOps, and Enterprise Cyber Defense.
Flagship Platforms: Sentinel APEX™ Intelligence Platform · Threat Intelligence API · Security Tools Hub · Enterprise Portal
Defending the Future with AI-Powered Cybersecurity.
Contact: bivash@cyberdudebivash.com · Website: https://cyberdudebivash.com